Jove
Visualize
Contact Us

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

1.3K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.3K
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

9.0K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
9.0K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

5.8K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.8K
Oral Hypoglycemic Agents: Glinides01:06

Oral Hypoglycemic Agents: Glinides

987
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
987
SBAR II: Application of SBAR01:14

SBAR II: Application of SBAR

6.9K
SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
6.9K
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

5.5K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
5.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Smart manufacturing for continuous downstream processing of monoclonal antibodies at the lab-scale.

SLAS technology·2026
Same author

Mediastinal Germ Cell Tumors: Up Close and Personal.

JMIR cancer·2026
Same author

Process Systems Engineering in Precision Medicine: Opportunities in Autologous CAR-T Therapy.

Engineering in life sciences·2026
Same author

Research Code Sharing in Support of Gold Standard Science.

Journal of diabetes science and technology·2026
Same author

Probabilistic Meal Detection and Estimation in Type 1 Diabetes With Extreme Shape Variability.

Journal of diabetes science and technology·2025
Same author

Response to "Hemodynamic gains or epinephrine echoes? Interpreting interposed abdominal compression cardiopulmonary resuscitation in pediatrics".

Resuscitation·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Apr 13, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.5K

Hypo- and Hyperglycemic Alarms: Devices and Algorithms.

Daniel Howsmon1, B Wayne Bequette2

  • 1Department of Chemical and Biological Engineering, Rensselaer Polytechnic Institute, Troy, NY, USA.

Journal of Diabetes Science and Technology
|May 2, 2015
PubMed
Summary
This summary is machine-generated.

Continuous glucose monitors (CGMs) are the best devices for detecting and warning of dangerous blood sugar fluctuations in diabetes management. These advanced systems offer superior reactive and predictive alarming for hypo- and hyperglycemia.

Keywords:
alarm systemscontinuous glucose monitoringhypoglycemialow glucose suspend

More Related Videos

Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique
07:35

Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique

Published on: January 26, 2024

2.4K
Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
11:10

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Published on: November 16, 2011

96.2K

Related Experiment Videos

Last Updated: Apr 13, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.5K
Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique
07:35

Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique

Published on: January 26, 2024

2.4K
Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
11:10

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Published on: November 16, 2011

96.2K

Area of Science:

  • Endocrinology and Diabetes Management
  • Biomedical Engineering and Device Technology

Background:

  • Hypoglycemia and hyperglycemia pose significant risks, recognized soon after insulin's discovery in 1922.
  • Effective monitoring is crucial for individuals with diabetes to manage blood glucose levels and prevent complications.

Purpose of the Study:

  • To review existing and emerging technologies designed to alert individuals to impending hypo- and hyperglycemia.
  • To evaluate the efficacy of various biosignals and devices for diabetes monitoring.

Main Methods:

  • Comprehensive review of literature on diabetes warning devices.
  • Analysis of biosignals utilized by different monitoring systems, including electroencephalography, electrocardiography, skin galvanic resistance, and diabetes alert dogs.
  • Focus on the performance and capabilities of continuous glucose monitors (CGMs).

Main Results:

  • Multiple biosignals and technologies have been explored for detecting glucose level deviations.
  • While other systems are improving in performance and size, continuous glucose monitors (CGMs) demonstrate superior capabilities.
  • CGM technology is identified as the optimal method for both immediate (reactive) and future (predictive) alerts.

Conclusions:

  • Continuous glucose monitoring (CGM) represents the most effective current technology for managing hypo- and hyperglycemia.
  • CGMs provide reliable reactive and predictive alarming, enhancing safety and quality of life for individuals with diabetes.
  • Ongoing advancements in CGM technology are expected to further improve diabetes care.